Background: Patients with an initial ischemic event secondary to atherosclerosis have an
increased risk of suffering a recurrent event not only in the same vascular territory, but in …

Background Peripheral arterial disease (PAD) affects more than 200 million of the global
population. PAD represents a marker for premature cardiovascular events. Patients with …

Peripheral arterial occlusive disease (PAD) is a highly prevalent atherosclerotic syndrome
associated with significant morbidity and mortality. It is defined by atherosclerotic obstruction …

Atherosclerosis within 2 or more arterial beds has been termed polyvascular disease.
Although polyvascular disease has long been associated with heightened cardiovascular …

Aims Patients with peripheral atherosclerotic disease often have multiple affected vascular
beds (AVB), however, data on long-term follow-up and medical therapy are scarce. We …

Background and aims Polyvascular disease (PVD) affects approximately 20% of patients
with atherosclerosis and is a strong independent risk factor for ischemic outcomes. However …

Polyvascular disease (PolyvascDis) with atherosclerosis occurring in> 2 vascular beds
(coronary, carotid, aortic, visceral and/or peripheral arteries) is encountered in 15-30% of …

In the last decades, due to aging communities and worse risk factor profiles, incidences of
peripheral artery disease (PAD) increased both in western and developing countries and …

Peripheral arterial disease (PAD) is a largely unrecognized complication of atherosclerotic
cardiovascular disease (ASCVD). Yet PAD is very much an issue for clinicians in the 21st …

Individuals with peripheral arterial disease (PAD) have a significantly elevated risk of
developing major cardiovascular complications, but, until recently, the atherosclerotic …